Platelet cytoskeleton and its hemostatic role

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 8, 2013, Pages 798-808

  Cerecedo, Doris ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

adhered platelets; dystroglycan; dystrophins; focal adhesions

Indexed keywords

ACTIN BINDING PROTEIN; DESMIN; DYSTROBREVIN; DYSTROPHIN; GLYCOPROTEIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; SYNTROPHIN; VASODILATOR STIMULATED PHOSPHOPROTEIN; VIMENTIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; CELL ADHESION; CELL GRANULE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CELLULAR SECRETION; HEMOSTASIS; HUMAN; INTERMEDIATE FILAMENT; MICROFILAMENT; MICROTUBULE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; ULTRASTRUCTURE;

BLOOD PLATELETS; CYTOSKELETAL PROTEINS; CYTOSKELETON; DYSTROGLYCANS; DYSTROPHIN; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SARCOGLYCANS;

EID: 84888132486     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328364c379     Document Type: Review

References (158)

1. Fox JE. The platelet cytoskeleton. Thromb Haemost 1993; 70:884-893.
2. Claessens MM, Semmrich C, Ramos L, Bausch AR. Helical twist controls the thickness of F-actin bundles. Proc Natl Acad Sci USA 2008; 105:8819-8822.
3. Fox JE, Boyles JK, Reynolds CC, Phillips DR. Actin filament content and organization in unstimulated platelets. J Cell Biol 1984; 98:1985-1991.
4. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003; 112:453-465.
5. Pellegrin S, Mellor H. Actin stress fibres. J Cell Sci 2007; 120:3491-3499.
6. Salbreux G, Prost J, Joanny JF. Hydrodynamics of cellular cortical flows and the formation of contractile rings. Phys Rev Lett 2009; 103:058102.
7. Escolar G, Krumwiede M, White JG. Organization of the actin cytoskeleton of resting and activated platelets in suspension. Am J Pathol 1986; 123:86-94.
8. Allen RD, Zacharski LR, Widirstky ST, Rosenstein R, Zaitlin LM, Burgess DR. Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy. J Cell Biol 1979; 83:126-142.
9. Bearer EL, Prakash JM, Li Z. Actin dynamics in platelets. Int Rev Cytol 2002; 217:137-182.
10. Nobes CD, Hall A. Rho, rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81:53-62.
11. Tomasevic N, Jia Z, Russell A, Fujii T, Hartman JJ, Clancy S, et al. Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2. Biochemistry 2007; 46:3494-3502.
12. Akbar H, Shang X, Perveen R, Berryman M, Funk K, Johnson JF, et al. Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation. PLoS One 2011; 6:e22117.
13. Hartwig JH. Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118:1421-1442.
14. Abraham VC, Krishnamurthi V, Taylor DL, Lanni F. The actin-based nanomachine at the leading edge of migrating cells. Biophys J 1999; 77:1721-1732.
15. Borisy GG, Svitkina TM. Actin machinery: pushing the envelope. Curr Opin Cell Biol 2000; 12:104-112.
16. Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci USA 1998; 95:6181-6186.
17. Li Z, Kim ES, Bearer EL. Arp2/3 complex is required for actin polymerization during platelet shape change. Blood 2002; 99:4466-4474.
18. Bender M, Eckly A, Hartwig JH, Elvers M, Pleines I, Gupta S, et al. ADF/ncofilin-dependent actin turnover determines platelet formation and sizing. Blood 2010; 116:1767-1775.
19. Nachmias VT, Golla R. Vinculin in relation to stress fibers in spread platelets. Cell Motil Cytoskeleton 1991; 20:190-202.
20. Reinhard M, Halbrugge M, Scheer U, Wiegand C, Jockusch BM, Walter U, et al. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J 1992; 11:2063-2070.
21. Bearer EL. Cytoskeletal domains in the activated platelet. Cell Motil Cytoskeleton 1995; 30:50-66.
22. Calaminus SD, Thomas S, McCarty OJ, Machesky LM, Watson SP. Identification of a novel, actin-rich structure, the actin nodule, in the early stages of platelet spreading. J Thromb Haemost 2008; 6:1944-1952.
23. Ponti A, Machacek M, Gupton SL, Waterman-Storer CM, DanuserG. Two distinct actin networks drive the protrusion of migrating cells. Science 2004; 305:1782-1786.
24. Alexandrova AY, Arnold K, Schaub S, Vasiliev JM, Meister JJ, Bershadsky AD, Verkhovsky AB. Comparative dynamics of retrograde actin flow and focal adhesions: formation of nascent adhesions triggers transition from fast to slow flow. PLoS One 2008; 3:e3234.
25. Corum LE, Eichinger CD, Hsiao TW, Hlady V. Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation. Langmuir 2011; 27:8316-8322.
26. Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 2006; 7:265-275.
27. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002; 4:E83-E90.
28. Schwarz Henriques S, Sandmann R, Strate A, Koster S. Force field evolution during human blood platelet activation. J Cell Sci 2012; 125:3914-3920.
29. Tanaka K, Itoh K. Reorganization of stress fiber-like structures in spreading platelets during surface activation. J Struct Biol 1998; 124:13-41.
30. Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol 1990; 111:1001-1007.
31. Gao G, Chen L, Dong B, Gu H, Dong H, Pan Y, et al. RhoA effector mDia1 is required for PI 3-kinase-dependent actin remodeling and spreading by thrombin in platelets. Biochem Biophys Res Commun 2009; 385:439-444.
32. Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005; 3:1752-1762.
33. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008; 112:3011-3025.
34. Humphries JD, Wang P, Streuli C, Geige B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007; 179:1043-1057.
35. Puklin-Faucher E, Sheetz MP. The mechanical integrin cycle. J Cell Sci 2009; 122:179-186.
36. Mierke CT. The role of vinculin in the regulation of the mechanical properties of cells. Cell Biochem Biophys 2009; 53:115-126.
37. Mitsios JV, Prevost N, Kasirer-Friede A, Gutierrez E, Groisman A, Abrams CS, et al. What is vinculin needed for in platelets? J Thromb Haemost 2010; 8:2294-2304.
38. Haling JR, Monkley SJ, Critchley DR, Petrich BG. Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood 2011; 117:1719-1722.
39. Moser M, Legate KR, Zent R, Fassler R. The tail of integrins, talin, and kindlins. Science 2009; 324:895-899.
40. Malinin NL, Plow EF, Byzova TV. Kindlins in FERM adhesion. Blood 2010; 115:4011-4017.
41. Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009; 15:306-312.
42. Malinin NL, Zhang L, Choi J, Ciocea A, Razorenova O, Ma YQ, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009; 15:313-318.
43. Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev 1982; 62:185-261.
44. White JG. Influence of microtubule stabilization on platelet physiology. Trans Assoc Am Physicians 1982; 95:264-271.
45. White JG, Rao GH. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol 1998; 152:597-609.
46. White JG. The substructure of human platelet microtubules. Blood 1968; 32:638-648.
47. Lewis SA, Gu W, Cowan NJ. Free intermingling of mammalian betatubulin isotypes among functionally distinct microtubules. Cell 1987; 49:539-548.
48. Lecine P, Italiano Jr JE, Kim SW, Villeval JL, Shivdasani RA. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood 2000; 96:1366-1373.
49. Patel-Hett S, Richardson JL, Schulze H, Drabek K, Isaac NA, Hoffmeister K, et al. Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood 2008; 111:4605-4616.
50. Schulze H, Dose M, Korpal M, Meyer I, Italiano JE Jr, Shivdasani RA. RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules. J Biol Chem 2008; 283:14109-14119.
51. Carazo-Salas RE, Gruss OJ, Mattaj IW, Karsenti E. Ran-GTP coordinates regulation of microtubule nucleation and dynamics during mitotic-spindle assembly. Nat Cell Biol 2001; 3:228-234.
52. Kunert S, Meyer I, Fleischhauer S, Wannack M, Fiedler J, Shivdasani RA, Schulze H. The microtubule modulator RanBP10 plays a critical role in regulation of platelet discoid shape and degranulation. Blood 2009; 114:5532-5540.
53. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987; 50:509-517.
54. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J 1990; 272:557-560.
55. Gorecki DC, Monaco AP, Derry JM, Walker AP, Barnard EA, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992; 1:505-510.
56. Rapaport D, Greenberg DS, Tal M, Yaffe D, Nudel U. Dp71, the nonmuscle product of the Duchenne muscular dystrophy gene is associated with the cell membrane. FEBS Lett 1993; 328:197-202.
57. Byers TJ, Lidov HG, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 1993; 4:77-81.
58. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 1995; 4:837-842.
59. Austin RC, Howard PL, D'Souza VN, Klamut HJ, Ray PN. Cloning and characterization of alternatively spliced isoforms of Dp71. Hum Mol Genet 1995; 4:1475-1483.
60. Khurana TS, Hoffman EP, Kunkel LM. Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem 1990; 265:16717-16720.
61. Wilson J, Putt W, Jimenez C, Edwards YH. Up71 and Up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum Mol Genet 1999; 8:1271-1278.
62. Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 2007; 1772:108-117.
63. Stone MR, O'Neill A, Catino D, Bloch RJ. Specific interaction of the actinbinding domain of dystrophin with intermediate filaments containing keratin 19. Mol Biol Cell 2005; 16:4280-4293.
64. Prins KW, Humston JL, Mehta A, Tate V, Ralston E, Ervasti JM. Dystrophin is a microtubule-associated protein. J Cell Biol 2009; 186:363-369.
65. Winder SJ, Ayscough KR. Actin-binding proteins. J Cell Sci 2005; 118:651-654.
66. Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. J Biol Chem 1991; 266:9161-9165.
67. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991; 66:1121-1131.
68. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992; 355:696-702.
69. Smalheiser NR, Kim E. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J Biol Chem 1995; 270:15425-15433.
70. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993; 122:809-823.
71. Smalheiser NR, Schwartz NB. Cranin: a laminin-binding protein of cell membranes. Proc Natl Acad Sci USA 1987; 84:6457-6461.
72. Talts JF, Andac Z, Gohring W, Brancaccio A, Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J 1999; 18:863-870.
73. Sugita S, Saito F, Tang J, Satz J, Campbell K, Sudhof TC. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 2001; 154:435-445.
74. Sato S, Omori Y, Katoh K, Kondo M, Kanagawa M, Miyata K, et al. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci 2008; 11:923-931.
75. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet 2001; 28:151-154.
76. Barresi R, Michele DE, KanagawaM, Harper HA, Dovico SA, Satz JS, et al. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 2004; 10:696-703.
77. Boffi A, Bozzi M, Sciandra F, Woellner C, Bigotti MG, Ilari A, Brancaccio A. Plasticity of secondary structure in the N-terminal region of betadystroglycan. Biochim Biophys Acta 2001; 1546:114-121.
78. Ervasti JM, Campbell KP. Dystrophin and the membrane skeleton. Curr Opin Cell Biol 1993; 5:82-87.
79. Oak SA, Zhou YW, Jarrett HW. Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1. J Biol Chem 2003; 278:39287-39295.
80. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995; 270:11711-11714.
81. Moore CJ, Winder SJ. Dystroglycan versatility in cell adhesion: a tale of multiple motifs. Cell Commun Signal 2010; 8:3.
82. Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 1993; 268:11496-11499.
83. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, et al. Betasarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995; 257:257-265.
84. Nigro V, Piluso G, Belsito A, Politano L, Puca AA, Papparella S, et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 1996; 5:1179-1186.
85. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 1999; 145:153-165.
86. Yang B, Ibraghimov-Beskrovnaya O,MoomawCR,SlaughterCA,Campbell KP. Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem 1994; 269:6040-6044.
87. Ahn AH, Yoshida M, Anderson MS, Feener CA, Selig S, Hagiwara Y, et al. Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24. Proc Natl Acad Sci USA 1994; 91:4446-4450
88. Sadoulet-Puccio HM, Khurana TS, Cohen JB, Kunkel LM. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ postsynaptic membrane. Hum Mol Genet 1996; 5:489-496.
89. Butler MH, Douville K, Murnane AA, Kramarcy NR, Cohen JB, Sealock R, Froehner SC. Association of the Mr 58 000 postsynaptic protein of electric tissue with Torpedo dystrophin and the Mr 87 000 postsynaptic protein. J Biol Chem 1992; 267:6213-6218.
90. Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, Sanes JR, et al. Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Cell Biol 1998; 142:1269-1278.
91. Ahn AH, Kunkel LM. Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol 1995; 128:363-371.
92. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 1996; 271:2724-2730.
93. Piluso G, Mirabella M, Ricci E, Belsito A, Abbondanza C, Servidei S, et al. Gamma1-and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem 2000; 275:15851-15860.
94. Wagner KR, Cohen JB, Huganir RL. The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron 1993; 10:511-522.
95. Blake DJ, Nawrotzki R, Peters MF, Froehner SC, Davies KE. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 1996; 271:7802-7810.
96. Puca AA, Nigro V, Piluso G, Belsito A, Sampaolo S, Quaderi N, et al. Identification and characterization of a novel member of the dystrobrevin gene family. FEBS Lett 1998; 475:7-13.
97. Nawrotzki R, Loh NY, Ruegg MA, Davies KE, Blake DJ. Characterisation of alpha-dystrobrevin in muscle. J Cell Sci 1998; 111 (Pt 17):2595-2605.
98. Dwyer TM, Froehner SC. Direct binding of Torpedo syntrophin to dystrophin and the 87 kDa dystrophin homologue. FEBS Lett 1995; 375:91-94.
99. Loh NY, Newey SE, Davies KE, Blake DJ. Assembly of multiple dystrobrevin-containing complexes in the kidney. J Cell Sci 2000; 113 (Pt 15):2715-2724.
100. Earnest JP, Santos GF, Zuerbig S, Fox JE. Dystrophin-related protein in the platelet membrane skeleton. Integrin-induced change in detergentinsolubility and cleavage by calpain in aggregating platelets. J Biol Chem 1995; 270:27259-27265.
101. Austin RC, Fox JE, Werstuck GH, Stafford AR, Bulman DE, Dally GY, et al. Identification of Dp71 isoforms in the platelet membrane cytoskeleton. Potential role in thrombin-mediated platelet adhesion. J Biol Chem 2002; 277:47106-47113.
102. Cerecedo D, Mart́nez-Rojas D, Chá vez O, Mart́nez-Pé rez F, Garc?á-Sierra F, Mornet D, et al. Platelet adhesion: structural and functional diversity of short dystrophin and utrophins in the formation of dystrophinassociated-protein complexes related to actin dynamics. Thromb Haemost 2005; 94:1203-1212.
103. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992; 360:588-591.
104. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, et al. Primary structure of dystrophin-related protein. Nature 1992; 360:591-593.
105. Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, et al. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 1999; 10:1299-1310.
106. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 1998; 4:1441-1444.
107. Forst J, Forst R, Leithe H, Maurin N. Platelet function deficiency in Duchenne muscular dystrophy. Neuromuscul Disord 1998; 8:46-49.
108. Maurin N, Forst J, Leithe H, Forst R. Deficiency of platelet glass bead adhesion and platelet membrane glycoprotein IV (CD36) in Duchenne muscular dystrophy. Thromb Haemost 1998; 79:1067.
109. Noordeen MH, Haddad FS, Muntoni F, Gobbi P, Hollyer JS, Bentley G. Blood loss in Duchenne muscular dystrophy: vascular smooth muscle dysfunction? J Pediatr Orthop B 1999; 8:212-215.
110. Turturro F, Rocca B, Gumina S, De Cristofaro R, Mangiola F, Maggiano N, et al. Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgery. Neuromuscul Disord 2005; 15:532-540.
111. Labarque V, Freson K, Thys C, Wittevrongel C, Hoylaerts MF, De Vos R, et al. Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery. Hum Mol Genet 2008; 17:357-366.
112. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984; 81:1189-1192.
113. Chapman VM, Miller DR, Armstrong D, Caskey CT. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USA 1989; 86:1292-1296.
114. Worton RG, Thompson MW. Genetics of Duchenne muscular dystrophy. Annu Rev Genet 1988; 22:601-629.
115. Cox GA, Phelps SF, Chapman VM, Chamberlain JS. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet 1993; 4:87-93.
116. Cerecedo D, Mondragon R, Candelario A, Garcia-Sierra F, Mornet D, Rendon A, Martinez-Rojas D. Utrophins compensate for Dp71 absence in mdx3cv in adhered platelets. Blood Coagul Fibrinolysis 2008; 19:39-47.
117. Ilsley JL, Sudol M, Winder SJ. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal 2002; 14:183-189.
118. Batchelor CL, Higginson JR, Chen YJ, Vanni C, Eva A, Winder SJ. Recruitment of Dbl by ezrin and dystroglycan drives membrane proximal Cdc42 activation and filopodia formation. Cell Cycle 2007; 6:353-363.
119. Ferletta M, Kikkawa Y, Yu H, Talts JF, Durbeej M, Sonnenberg A, et al. Opposing roles of integrin alpha6Abeta1 and dystroglycan in lamininmediated extracellular signal-regulated kinase activation. Mol Biol Cell 2003; 14:2088-2103.
120. Jones JC, Lane K, Hopkinson SB, Lecuona E, Geiger RC, Dean DA, et al. Laminin-6 assembles into multimolecular fibrillar complexes with perlecan and participates in mechanical-signal transduction via a dystroglycandependent, integrin-independent mechanism. J Cell Sci 2005; 118:2557-2566.
121. Peng H, Shah W, Holland P, Carbonetto S. Integrins and dystroglycan regulate astrocyte wound healing: the integrin beta1 subunit is necessary for process extension and orienting the microtubular network. Dev Neurobiol 2008; 68:559-574.
122. Thompson O, Moore CJ, Hussain SA, Kleino I, Peckham M, Hohenester E, et al. Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan. J Cell Sci 2010; 123:118-127.
123. Waterman-Storer CM, Salmon E. Positive feedback interactions between microtubule and actin dynamics during cell motility. Curr Opin Cell Biol 1999; 11:61-67.
124. Cerecedo D, Cisneros B, Suá rez-Sánchez R, Hernández-Gonzá lez E, Galván I. b-dystroglycan modulates the interplay between actin and microtubules in human adhered platelets. Br J Haematol 2008; 141:517-528.
125. Cerecedo D, Mondragon R, Cisneros B, Martinez-Perez F, Martinez-Rojas D, Rendon A. Role of dystrophins and utrophins in platelet adhesion process. Br J Haematol 2006; 134:83-91.
126. Heijnen HF, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998; 91:2313-2325.
127. White JG. The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles. Blood 1969; 33:598-606.
128. Van Nispen tot Pannerden H, de Haas F, Geerts W, Posthuma G, van Dijk S, Heijnen HF. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 2010; 116:1147-1156.
129. Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007; 5:2009-2016.
130. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al. Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111:1227-1233.
131. Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, Zhu L, et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 2011; 117:3907-3911.
132. Ma L, Perini R, McKnight W, Dicay M, Klein A, Hollenberg MD, Wallace JL. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 2005; 102:216-220.
133. Battinelli EM, Markens BA, Italiano JE Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011; 118:1359-1369.
134. Rex S, Beaulieu LM, Perlman DH, Vitseva O, Blair PS, McComb ME, et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alphagranule release. Thromb Haemost 2009; 102:97-110.
135. Etulain J, Lapponi MJ, Patrucchi SJ, Romaniuk MA, Benzadon R, Klement GL, et al. Hyperthermia inhibits platelet hemostatic functions and selectively regulates the release of alpha-granule proteins. J Thromb Haemost 2011; 9:1562-1571.
136. Peters CG, Michelson AD, Flaumenhaft R. Granule exocytosis is required for platelet spreading: differential sorting of alpha-granules expressing VAMP-7. Blood 2012; 120:199-206.
137. Woronowicz K, Niederman RA. Proteomic analysis of the developing intracytoplasmic membrane in Rhodobacter sphaeroides during adaptation to low light intensity. Adv Exp Med Biol 2010; 675:161-178.
138. Flaumenhaft R, Dilks JR, Rozenvayn N, Monahan-Earley RA, Feng D, Dvorak AM. The actin cytoskeleton differentially regulates platelet alphagranule and dense-granule secretion. Blood 2005; 105:3879-3887.
139. Cerecedo D, Cisneros B, Mondragon R, Gonzalez S, Galvan IJ. Actin filaments and microtubule dual-granule transport in human adhered platelets: the role of alpha-dystrobrevins. Br J Haematol 2010; 149:124-136.
140. Macioce P, Gambara G, Bernassola M, Gaddini L, Torreri P, Macchia G, et al. Beta-dystrobrevin interacts directly with kinesin heavy chain in brain. J Cell Sci 2003; 116:4847-4856.
141. Ge S, White JG, Haynes CL. Cytoskeletal F-actin, not the circumferential coil of microtubules, regulates platelet dense-body granule secretion. Platelets 2012; 23:259-263.
142. Hyder CL, Pallari HM, Kochin V, Eriksson JE. Providing cellular signposts-posttranslational modifications of intermediate filaments. FEBS Lett 2008; 582:2140-2148.
143. Ku NO, Liao J, Omary MB. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J 1998; 17:1892-1906.
144. Carmo-Fonseca M, David-Ferreira JF. Interactions of intermediate filaments with cell structures. Electron Microsc Rev 1990; 3:115-141.
145. Minin AA, Moldaver MV. Intermediate vimentin filaments and their role in intracellular organelle distribution. Biochemistry (Mosc) 2008; 73:1453-1466.
146. Oriolo AS, Wald FA, Ramsauer VP, Salas PJ. Intermediate filaments: a role in epithelial polarity. Exp Cell Res 2007; 313:2255-2264.
147. Cohen TV, Hernandez L, Stewart CL. Functions of the nuclear envelope and lamina in development and disease. Biochem Soc Trans 2008; 36:1329-1334.
148. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22:832-853.
149. Parnaik VK. Role of nuclear lamins in nuclear organization, cellular signaling, and inherited diseases. Int Rev Cell Mol Biol 2008; 266:157-206.
150. Bousquet O, Ma L, Yamada S, Gu C, Idei T, Takahashi K, et al. The nonhelical tail domain of keratin 14 promotes filament bundling and enhances the mechanical properties of keratin intermediate filaments in vitro. J Cell Biol 2001; 155:747-754.
151. Herrmann H, Bar H, Kreplak L, Strelkov SV, Aebi U. Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Mol Cell Biol 2007; 8:562-573.
152. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 1998; 111 (Pt 17):2477-2486.
153. Helfand BT, Mikami A, Vallee RB, Goldman RD. A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization. J Cell Biol 2002; 157:795-806.
154. Li Z, Mericskay M, Agbulut O, Butler-Browne G, Carlsson L, Thornell LE, et al. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 1997; 139:129-144.
155. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 1996; 134:1255-1270.
156. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000; 150:1283-1298.
157. Tablin F, Taube D. Platelet intermediate filaments: detection of a vimentinlike protein in human and bovine platelets. Cell Motil Cytoskeleton 1987; 8:61-67.
158. Cerecedo D, Martinez-Vieyra I, Mondragon R, Mondragon M, Gonzalez S, Galvan IJ. Haemostatic role of intermediate filaments in adhered platelets: importance of the membranous system stability. J Cell Biochem 2013;114:2050-2060.